March 01, 2018 08:00 AM Eastern Standard Time
ALAMEDA, Calif.–(BUSINESS WIRE)–AgeX Therapeutics, Inc., a subsidiary of BioTime, Inc. (NYSE American: BTX) today announced that the company’s Chief Executive Officer Michael D. West, Ph.D. will participate at three upcoming conferences: the Mauldin Economics Strategic Investment Conference, March 6-9 in San Diego; Undoing Aging, March 15-17 in Berlin, Germany; and the 10th World Congress and Expo on Cell & Stem Cell Research, March 19-21 in New York City.
“Induced tissue regeneration (iTR): Leveraging the unique regenerative potential of pluripotent stem cell-derived therapeutics.”

The Mauldin Economics Strategic Investment Conference
March 6-9 in San Diego, California
AgeX session: Wednesday, March 7, 1:50pm PST
Dr. West and AgeX’s VP of New Technology Discovery Aubrey de Grey, Ph.D. will participate on the Biotech panel, along with Eric Verdin, M.D., President and CEO of the Buck Institute for Research on Aging.

Undoing Aging
March 15-17 in Berlin, Germany
AgeX presentation: Friday, March 16 at 11:30am CET
Dr. West will discuss the prospect of using stem cell-derived cells for the treatment of age-related degenerative conditions.
The conference is being organized in part by Dr. de Grey in his capacity as Chief Science Officer of the SENS Research Foundation, which is co-sponsoring the event.

The 10th World Congress and Expo on Cell & Stem Cell Research
March 19-21 in New York City
AgeX presentation: Tuesday, March 20 at 9:00am EDT
Dr. West will deliver a presentation titled, “Induced tissue regeneration (iTR): Leveraging the unique regenerative potential of pluripotent stem cell-derived therapeutics.”
A copy of Dr. West’s presentations will be available on the AgeX website.

 

WE WELCOME YOUR VIEWS

Please enter your comment!
Please enter your name here